ReviewThe Lancet. Oncology2021
The International Collaboration for Research methods Development in Oncology (CReDO) workshops: shaping the future of global oncology research.
Review in The Lancet. Oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.
- Sympathetic nerve blocks for persistent pain in adults with inoperable abdominopelvic cancer.The Cochrane database of systematic reviews · 2024Pooled it
- Networking in Orthopedics: Collaboration, Opportunities, Education, and Research in Orthopedics.Journal of orthopaedic case reports · 2026Article
- Patient and public involvement in cancer care and research: the Indian perspective.Ecancermedicalscience · 2026Review
- Exploring adaptive health technology assessment for evaluating 10 cancer interventions: insights and lessons from a pilot study in India.BMJ evidence-based medicine · 2025Article
- First-line pembrolizumab for metastatic NSCLC in lower-middle-income countries: bridging the efficacy-effectiveness gap.Immunotherapy · 2025Article
- Barriers and Opportunities for Cancer Clinical Trials in Low- and Middle-Income Countries.JAMA network open · 2025Article
- Protocol-in-a-Day Workshop: Expediting IRB Approval for Junior and Senior Faculty.Journal of cancer education : the official journal of the American Association for Cancer Education · 2025Article
- Growing the global cancer care system: success stories from around the world and lessons for the future.Journal of the National Cancer Institute · 2024Article
- Landscape of cancer clinical trials in India - a comprehensive analysis of the Clinical Trial Registry-India.The Lancet regional health. Southeast Asia · 2024Article
- Standardizing the Head and Neck Cancer Treatment and Research.Indian journal of surgical oncology · 2023Review
- Impact of COVID-19 on healthcare system in India: A systematic review.Journal of public health research · 2023Review
- Radiation Oncology Research in Asia: Current Status and a Peep Into the Future From the Federation of Asian Organizations for Radiation Oncology.JCO global oncology · 2023Article
- Tri-modality therapy in advanced esophageal carcinoma: long-term results and insights from a developing world, institutional cohort.The British journal of radiology · 2023Article
- Global cancer surgery in low-resource settings: A strengths, weaknesses, opportunities, and threats analysis.Cancer · 2023Review
- An analysis of the African cancer research ecosystem: tackling disparities.BMJ global health · 2023Article
- Cancer Survivorship in the Indo-Pacific: Priorities for Progress.JCO global oncology · 2023Review
- Globalisation of industry-sponsored clinical trials for breast, lung and colon cancer research: trends, threats and opportunities.BMJ oncology · 2023Article
- Cancer research across Africa: a comparative bibliometric analysis.BMJ global health · 2022Article
- Perspectives of Zambian Clinical Oncology Trainees in the MD Anderson and Zambia Virtual Clinical Research Training Program (MOZART).The oncologist · 2022Article
- Participation of Lower and Upper Middle-Income Countries in Clinical Trials Led by High-Income Countries.JAMA network open · 2022Article
Corrections and comments
- Commented on by
Authors and funding
28 authors at 20 institutions in 9 countries.
Funding
Abstract
Low-income and middle-income countries (LMICs) have a disproportionately high burden of cancer and cancer mortality. The unique barriers to optimum cancer care in these regions necessitate context-specific research. The conduct of research in LMICs has several challenges, not least of which is a paucity of formal training in research methods. Building capacity by training early career researchers is essential to improve research output and cancer outcomes in LMICs. The International Collaboration for Research methods Development in Oncology (CReDO) workshop is an initiative by the Tata Memorial Centre and the National Cancer Grid of India to address gaps in research training and increase capacity in oncology research. Since 2015, there have been five CReDO workshops, which have trained more than 250 oncologists from India and other countries in clinical research methods and protocol development. Participants from all oncology and allied fields were represented at these workshops. Protocols developed included clinical trials, comparative effectiveness studies, health services research, and observational studies, and many of these protocols were particularly relevant to cancer management in LMICs. A follow-up of these participants in 2020 elicited an 88% response rate and showed that 42% of participants had made progress with their CReDO protocols, and 73% had initiated other research protocols and published papers. In this Policy Review, we describe the challenges to research in LMICs, as well as the evolution, structure, and impact of CReDO and other similar workshops on global oncology research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.